<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966056</url>
  </required_header>
  <id_info>
    <org_study_id>01_M012_3210</org_study_id>
    <nct_id>NCT00966056</nct_id>
  </id_info>
  <brief_title>Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae</brief_title>
  <official_title>Comparative Study of Mitomycin C and Internal Nasal Septal Splint in the Treatment of Nasal Synechiae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karnataka Institute of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karnataka Institute of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether Mitomycin C is an effective alternative to septal splints in the
      treatment of nasal synechiae.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nasal synechiae is an important cause for the failure of many a nasal surgery. Septal splints
      have been widely used for the treatment of nasal synechiae, but are associated significant
      morbidity until removal. To the best of our knowledge there are no studies in literature
      comparing Mitomycin C with septal splints as an atraumatic alternative in the treatment of
      nasal synechiae. This is a preliminary study taken up to evaluate the therapeutic efficacy of
      Mitomycin C in the treatment of nasal synechiae.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence or absence of synechiae</measure>
    <time_frame>1 week, 1 month, 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms and complications</measure>
    <time_frame>1 week, 1 month, 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Nasal Synechiae</condition>
  <condition>Adhesions of Nasal Cavity</condition>
  <condition>Nasal Adhesions</condition>
  <condition>Tissue Adhesions</condition>
  <arm_group>
    <arm_group_label>Mitomycin C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cases recruited into this arm receive topical application of mitomycin c (1mg/ml)following surgical synechiolysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Teflon septal splint</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cases recruited into this arm receive insertion of teflon internal nasal septal splint following surgical synechiolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mitomycin C</intervention_name>
    <description>Cotton wick soaked with 1mg/ml of mitomycin c placed for 2 minutes between the raw surfaces after synechiolysis with surgical blade no.15</description>
    <arm_group_label>Mitomycin C</arm_group_label>
    <other_name>Mitomycin, Mitocin, MMC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Teflon nasal septal splint</intervention_name>
    <description>Teflon internal nasal septal splint placed between the raw surfaces and secured at the anterior end of septum with catgut 3-0 sutures, following synechiolysis with surgical blade no.15. Splint removed at the end of one week</description>
    <arm_group_label>Teflon septal splint</arm_group_label>
    <other_name>Teflon splint, nasal septal splint, internal nasal splint</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with nasal mucosal synechiae due to surgical or non-surgical trauma

        Exclusion Criteria:

          -  Patients with nasal vestibular stenosis

          -  Patients with nasal synechiae due to diseases like Hansen's disease, Syphilis,
             Rhinoscleroma, Atrophic Rhinitis etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>VIKRAM K BHAT, MS(ENT), DNB</last_name>
    <role>Study Chair</role>
    <affiliation>Karnataka Institute of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karnataka Institute of Medical Sciences</name>
      <address>
        <city>Hubli</city>
        <state>Karnataka</state>
        <zip>580022</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2009</study_first_submitted>
  <study_first_submitted_qc>August 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2009</study_first_posted>
  <last_update_submitted>July 7, 2011</last_update_submitted>
  <last_update_submitted_qc>July 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr SRINISH G</name_title>
    <organization>KARNATAKA INSTITUTE OF MEDICAL SCIENCES</organization>
  </responsible_party>
  <keyword>Nasal adhesions</keyword>
  <keyword>Nasal synechiae</keyword>
  <keyword>Mitomycin</keyword>
  <keyword>Mitomycin c</keyword>
  <keyword>Teflon</keyword>
  <keyword>Splints</keyword>
  <keyword>Septal splints</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

